v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 25,626 $ 21,533
General and administrative 7,609 5,292
Total operating expenses 33,235 26,825
Loss from operations (33,235) (26,825)
Other income:    
Interest income 760 183
Other income (expense), net (113) 1,169
Total other income 647 1,352
Net loss $ (32,588) $ (25,473)
Net loss per share, basic (in usd per share) $ (1.08) $ (2.51)
Net loss per share, diluted (in usd per share) $ (1.08) $ (2.51)
Weighted-average common shares outstanding, basic (in shares) 30,136,324 10,134,443
Weighted-average common shares outstanding, diluted (in shares) 30,136,324 10,134,443